Shared Risk Factors for Cardiovascular Disease and Cancer: Implications for Preventive Health and Clinical Care in Oncology Patients
Christopher Johnson(University of Ottawa), Jeffrey Sulpher(BC Cancer Agency), Margot K. Davis(University of British Columbia), Angeline Law(University of Ottawa)
Cited by 173
Related Papers
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
|Canadian Journal of Cardiology|2021|290
Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
|Canadian Journal of Cardiology|2016|234
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
|Canadian Journal of Cardiology|2020|121
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
|Canadian Journal of Cardiology|2020|112
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
|Echo Research and Practice|2016|56